Company CVAbout Torrent Pharmaceuticals Ltd. 
Torrent Pharmaceuticals Ltd.
Large Cap
Pharmaceuticals & Biotechnology
Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments. The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation. The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
Company Coordinates
Company Details
Torrent House, Off Ashram Road Ahmedabad Gujarat : 380009
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 169.22 Cr
Number of Shares
33.84 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Jul-2022
33.84
169.22
169207520
5
Bonus Issue
04-Feb-2019
16.92
84.60
-14000
5
Forfeited Shares
12-Sep-2016
16.92
84.61
400
5
Allotment of Equity To Others
12-Sep-2016
16.92
84.61
400
5
Allotment of Equity To Others
11-Mar-2016
16.92
84.61
800
5
Allotment of Equity To Others
11-Mar-2016
16.92
84.61
800
5
Allotment of Equity To Others
30-Sep-2013
16.92
84.61
4140
5
Unspecified
30-Sep-2013
16.92
84.61
4140
5
Unspecified
23-Jul-2013
16.92
84.61
84607220
5
Bonus
23-Jul-2013
16.92
84.61
84607220
5
Bonus
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 40 Schemes (5.12%)
FIIs
Held by 803 FIIs (15.92%)
Promoter with highest holding
Torrent Investments Limited (formerly Known As Torrent Investments Private Limited) (68.31%)
Highest Public shareholder
Nps Trust (1.89%)
Individual Investors Holdings
4.08%
Board of Directors
Management
Designation
Remuneration
Sudhir Mehta
Chairman Emeritus
0
Samir Mehta
Executive Chairman
23.0 cr
Shailesh Haribhakti
Independent Director
89.0 lacs
H Khaitan
Independent Director
83.0 lacs
Ameera Shah
Independent Director
69.0 lacs
Nayantara Bali
Independent Director
79.0 lacs
Jinesh Shah
Director (Operation)
5.89 cr
Maurice Chagnaud
Independent Director
71.0 lacs
Aman Mehta
Whole Time Director
2.06 cr
Manish Choksi
Independent Director
42.0 lacs
Chintan Trivedi
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Sale of Products - Pharmaceutical
5,619.68
96.47%
Other Operating Income - Export Benefits
76.17
1.31%
Other Operating Income - Compensation and Settlement Income
62.81
1.08%
Sale of Products - Pharmaceutical
Sale of Products - Pharmaceutical
Other Operating Income - Export Benefits
Other Operating Income - Export Benefits
Other Operating Income - Compensation and Settlement Income
Other Operating Income - Compensation and Settlement Income
Stock DNARevenue and Profits:
Net Sales:
3,302 Cr
(Quarterly Results - Sep 2025)
Net Profit:
591 Cr
Pharmaceuticals & Biotechnology
INR 127,825 Cr (Large Cap)
59.00
34
0.68%
0.24
25.66%
15.23
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
